Early release of macrophage migration inhibitory factor after liver ischemia and reperfusion injury in rats

Area of Science:

• Immunology
• Hepatology
• Transplantation

Background:

• Macrophage migration inhibitory factor (MIF) is a key mediator in ischemia/reperfusion (I/R) injury across multiple organs.
• The specific role of MIF in liver I/R injury, particularly following transplantation, remains largely uncharacterized.
• Previous studies confirmed MIF release during in vitro warm and cold ischemia.

Purpose of the Study:

• To investigate the hypothesis that MIF acts as an early proinflammatory cytokine in liver I/R injury.
• To determine the role of MIF in mediating inflammatory damage following liver I/R and liver transplantation (LTx).
• To analyze the expression of MIF, its receptor (CD74), and downstream inflammatory cytokines (TNF-α, IL-1β) in liver I/R models.

Main Methods:

• Rats underwent warm ischemia (90 min) followed by reperfusion (0.5h, 6h, 24h) or liver transplantation (6h cold ischemia, 24h reperfusion).
• Hepatic mRNA and protein expression of MIF, CD74, TNF-α, and IL-1β were analyzed.
• Peritoneal macrophages were cultured with effluent from cold-preserved livers, with and without MIF, to assess cytokine induction.

Main Results:

• Warm I/R significantly increased hepatic MIF mRNA and protein expression.
• MIF protein was detected in peripheral circulation post-reperfusion, peaking at 0.5h.
• MIF expression correlated with increased levels of CD74, TNF-α, and IL-1β.
• Effluent from cold-preserved livers induced TNF-α and IL-1β production in macrophages; MIF depletion reduced this effect.

Conclusions:

• Intrahepatic upregulation and systemic release of MIF following liver I/R suggest its involvement in the inflammatory response.
• MIF appears to act as an early proinflammatory mediator, contributing to liver I/R injury.
• Targeting MIF may offer a novel therapeutic strategy for preventing hepatic I/R injury.